• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Anthem Blue Cross Blue Shield

NeoTract’s UroLift system gains expanded insurance coverage

February 15, 2019 By Nancy Crotti

Teleflex (NYSE:TFX) subsidiary NeoTract said that two more health insurers have agreed to offer coverage for the company’s UroLift system or patients with an enlarged prostate. The Wayne, Penn.-based subsidiary of Teleflex said that major U.S. insurer Humana and the Motion Picture Industry Pension & Health Plans (MPI), administered by Anthem Blue Cross, have added UroLift to its […]

Filed Under: Business/Financial News, Featured, Implants, News Well, Urology Tagged With: Anthem Blue Cross Blue Shield, Humana, NeoTract, Teleflex

Abiomed lands reimbursement expansion for Impella heart pump

March 11, 2013 By Sony Salzman Leave a Comment

Abiomed

Abiomed (NSDQ:ABMD) won expanded reimbursement for its flagship Impella heart pump from 4 private and Medicare Advantage insurers, including 1 of the largest names in the industry.

Humana, UnitedHealthcare Medicare Risk, Independence Blue Cross and Capital Blue Cross. The expanded coverage at the private or Medicare Advantage plans includes new Impella policies.

Filed Under: News Well, Structural Heart Tagged With: Abiomed, Anthem Blue Cross Blue Shield, Humana, UnitedHealth Group

Occlutech CEO: St. Jude’s patent suit against me “amazing and quite shocking” | Legal News

September 30, 2011 By MassDevice staff Leave a Comment

Occlutech
St. Jude Medical

A patent spat between St. Jude Medical (NYSE:STJ) and Occlutech GmbH that morphed into a personal lawsuit against Occlutech CEO Tor Peters was dismissed by a German court, prompting Peters to call the suit "amazing and quite shocking."

St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Anthem Blue Cross Blue Shield, Argentum Medical, Covidien, Ethicon, HemCon Medical Technologies Inc., ICU Medical Inc., Johnson and Johnson, Legal Roundup, Marine Polymer Technologies Inc., Noble Biomaterials, Occlutech GmbH, RyMed Technologies Inc., stjudemedical, Zynex Inc.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS